On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


JGR Capital Reports on Five Cannabis-Related Companies

The U.S. now has 22 states that have legalized medical marijuana, 16 that have approved the usage of CBD and THC products and eight that have legalized recreational cannabis use. Marijuana use in Canada is generally legalized, and there is a total of 105 authorized licensed producers (LPs), with eight provinces allowing homegrown cannabis. In a recent report, JGR Capital, a New York-based equity research firm, highlighted the largest single U.S. cannabis company listed on the Canadian exchange, plus four cannabis-related companies that have raised capital.

Los Angeles-based cannabis producer MM Enterprises, now renamed MedMen Enterprises (CSE: MMEN) following a reverse merger, is the largest U.S. cannabis company listed on the Canadian Securities Exchange. The company’s short position in cannabis-related stocks reached a record high of over 200 million shares. Through a private placement, the company has raised C$143 million, placing the value of the organization at C$2.14 billion ($1.65 billion).

Emerald Health Therapeutics (OTCQX: EMHTF) recently announced that it closed the sale of four million share units for gross proceeds of C$16.80 million (~$13.04 million). Net proceeds will go toward further development of projects in Las Vegas, Washington State and California.

Speakeasy Cannabis Club (OTC: SPBBF) recently closed the first tranche of its non-brokered private placement of 4.9 million units, bringing in gross proceeds of C$4.90 million (~$3.80 million). The proceeds of this private placement will go toward general working capital.

Village Farms Internationals (OTCQX: VFFIF) completed a private placement of company shares for gross proceeds of approximately C$10 million (~$7.76 million). Net proceeds from this offering will be used to contribute capital, if required, to Pure Sunfarms, as well as general working capital purposes. Pure Sunfarms is a 50 percent-owned JV with Emerald Health Therapeutics, and it is currently increasing commercial production at its 1.1 million sq. ft. greenhouse.

For more information, view the complete JGR Capital report at http://ibn.fm/CT5zg

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.